![Prof Erik Stroes](https://www.triglycerideforum.org/wp-content/uploads/2021/09/erik-stroes-300x300-1-150x150.jpg)
ApoCIII and ANGPTL3 inhibition: A breakthrough in lowering triglyceride-rich lipoproteins?
Professor Erik SG StroesWatch the presentation >
![Gabriel Steg](https://www.triglycerideforum.org/wp-content/uploads/2022/05/steg-g-pcsk9-150x150.png)
REDUCE-IT subgroup analyses: New insights
Professor P Gabriel StegWatch the presentation >
![Dr Michael Miller](https://www.triglycerideforum.org/wp-content/uploads/2022/01/michael-miller-180-150x150.jpg)
Omega-3 fatty acids for cardiovascular risk reduction: A long and winding road
Dr Michael MillerWatch the presentation >
![](https://www.triglycerideforum.org/wp-content/uploads/2022/04/BartStaels-150x150.png)
Novel PPAR agonists as therapeutics in hypertriglyceridaemia
Professor Bart StaelsWatch the presentation >
![Marja-Riita Taskinen](https://www.triglycerideforum.org/wp-content/uploads/2020/12/Taskinen-MR_cropped-150x150.jpg)
Keynote – What have we learned from triglyceride lowering trials using fibrates over the past 40 years?
Professor Marja-Riitta TaskinenWatch the presentation >
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
![Arrowhead Pharmaceuticals](https://www.triglycerideforum.org/wp-content/uploads/2023/10/arrowhead_logo.png)
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
![Ionis Logo](https://www.triglycerideforum.org/wp-content/uploads/2021/08/IonisLogo.png)
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
![Kowa Logo](https://www.triglycerideforum.org/wp-content/uploads/2020/11/kowaEnglish_mark.jpg)